SIGNIFOR LAR subst sèche 30 mg cum solv flac
7680651480050
CH-65148
H01CB05
07.16.2.
Reimbursement limitations:
SIGNIFOR LAR
Signifor LAR est indiqué dans le traitement de l’acromégalie chez les patients, qui n’ont pas …
1 / 3
google
Details
- Product number
- 6514805
- CPT
- -
- Packaging group
- 1x30 mg
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: pasireotidum 30 mg ut pasireotidi pamoas, poly(lactidum-co-glycolidum), pro vitro. Solvens: mannitolum, carmellosum natricum corresp. natrium 1.5 mg, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Signifor LAR 30 mg, Pulver und Lösung zur Herstellung einer Injektionssuspension
Pulver
1x30 mg
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | WIZUS |
|
SOLV
|
1.5 MG | Substance | HBESI |
|
PRS
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
Authorization holder
RECORDATI AG
4057 Basel
Authorization information
- Swissmedic authorization number
- 65148
- Drug name
- Signifor LAR, Pulver und Lösung zur Herstellung einer Suspension zur Injektion
- Galenic form
- PULP
- ATC Code
- H01CB05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/02/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIGNIFOR LAR subst sèche 30 mg cum solv flac
- Description (DE)
- SIGNIFOR LAR Trockensub 30 mg cum Solv Durchstf
- Market launch
- 19/07/2018
- Narcotic (BTM)
- No